Quick10K

⚲

Invesco DB Precious Metals Fund

Filings

10-Q	2021-03-31	Filed 2021-05-07
10-K	2020-12-31	Filed 2021-02-26
10-Q	2020-09-30	Filed 2020-11-06
10-Q	2020-06-30	Filed 2020-08-07
10-Q	2020-03-31	Filed 2020-05-08
10-K	2019-12-31	Filed 2020-02-28
10-Q	2019-09-30	Filed 2019-11-08
10-Q	2019-06-30	Filed 2019-08-08
10-Q	2019-03-31	Filed 2019-05-09
10-K	2018-12-31	Filed 2019-02-28
S-1	2018-11-15	Public Filing
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-08
10-K	2017-12-31	Filed 2018-02-28
10-Q	2017-09-30	Filed 2017-11-09
10-Q	2017-06-30	Filed 2017-08-08
10-Q	2017-03-31	Filed 2017-05-08
10-K	2016-12-31	Filed 2017-03-01
10-Q	2016-09-30	Filed 2016-11-08
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-10
10-K	2015-12-31	Filed 2016-02-29
10-Q	2015-09-30	Filed 2015-11-06
10-Q	2015-06-30	Filed 2015-08-10
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-06
10-Q	2014-09-30	Filed 2014-11-05
10-Q	2014-06-30	Filed 2014-08-06
10-Q	2014-03-31	Filed 2014-05-09
10-K	2013-12-31	Filed 2014-03-04
10-Q	2013-09-30	Filed 2013-11-05
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-03
10-K	2012-12-31	Filed 2013-03-01
10-Q	2012-09-30	Filed 2012-11-02
10-Q	2012-06-30	Filed 2012-08-03
10-Q	2012-03-31	Filed 2012-05-14
10-K	2011-12-31	Filed 2012-03-14
10-Q	2011-09-30	Filed 2011-11-07
10-Q	2011-06-30	Filed 2011-08-05
10-Q	2011-03-31	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-03-14
10-Q	2010-09-30	Filed 2010-11-05
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-10
10-K	2009-12-31	Filed 2010-03-08

Reports

8-K	2020-04-02
8-K	2019-10-01
8-K	2019-05-07
8-K	2018-08-27
8-K	2018-06-04
8-K	2018-05-24
8-K	2018-03-08

Invesco DB Precious Metals Fund Financials

DBP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	34,848	102,003	65,165	6,894	39,635	37,831	85,390	27,483	99,748	14,539	9,719	11,967	3,823	10,667	15,350	14,858	6,831	5,077	3,454	3,436	12,062	632	1,975				671	0	0	0		0	0	0
Accounts Receivable
Inventory
PP&E
Assets	551,464	509,615	465,298	420,848	338,479	357,725	354,257	302,305	216,910	230,104	183,320	200,610	198,717	170,586	156,790	146,356	130,831	110,079	96,949	156,598	220,006	293,411	140,843	160,311	156,398	168,001	154,829	177,929	132,255	110,441	110,002	116,176	116,466	133,936
Accounts Payable
Long-Term Debt
Liabilities	359	388	11,150	284	202	415	235	190	161	3,151	3,119	10,127	10,116	3,115	3,099	13,401	918	1,069	106	103	409	1,617	1,111	102	501	822	98	404	89	72	1,121	81	72	3,438
Stockholders' Equity	551,105	509,227	454,148	420,563	338,277	357,310	354,022	302,115	216,750	226,953	180,200	190,483	188,600	167,471	153,690	132,955	129,913	109,010	96,844	156,495	219,596	291,794	139,732	160,209	155,897	167,179	154,731	177,525	132,166	110,368	108,881	116,095	116,394	130,498


Income Statement ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income	-17,719	20,986	-25,478	35,028	-11,662	39,856	-29,463	-15,489	-78,382	19,453	-23,283	9,585	6,119	-21,965	-6,119	1,982	-3,021	-6,736	-5,038	15,121	15,359	-4,819	-31,761	13,109	-5,071	3,714	2,889	-201	-6,827	-7,378		-410	7,353	6,308


Cash Flow ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		130,018	-18,050	21,156	89,322	19,019	21,385	-21,490	79,248	-75,959	18,650	1,550	-143	6,008	12,346	22,225		12,413		-44,549	-39,117	-88,446	121,644	-9,344	-759	-7,568	16,007	-23,666		14,420		-6,578	7,054	-7,796
Cash Investing
Cash Financing		-62,863	-18,788	-79,426	-56,581	-20,823	26,174	-36,418	-6,983	-9,250	-23,470	698	-8,002	836	-7,662	-22,718	-20			44,531	47,743	77,016	-120,301	7,368	759	7,568	-15,336	22,996		-14,420		6,578	-7,054	7,796